ATB1651

· AmtixBio Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATB1651, covering 2025-02-19 to 2025-02-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis [Phase 2]